Marinomed Biotech AG announces results for the first quarter of 2025
Marinomed Biotech AG: Launch of new moisturizing Carragelose eye drops in Austria
Ad-hoc: Marinomed Biotech AG has been a victim of cybercrime
Marinomed focuses on growth after successful restructuring
Public Relations